Company Presentation

Recolony AG

Category:Emerging Biotech Company
Date:April 25, 2023
Speaker:Egle Katkeviciute, Chief Scientific Officer

Company profile

At Recolony, we focus our efforts in developing cancer therapies that primarily consist of selected commensal bacteria of the gut microbiota. By harnessing the potential of beneficial gut microbiota, Recolony aims to develop a completely new class of drugs for the treatment and prevention of cancer. Our aim is to shift the paradigm of cancer treatment away from single-target-drugs towards a gut microbiota guided activation of the immune system.

Follow us